EnginZyme raises €21 million in Series B to accelerate the commercialisation of its cell-free biomanufacturing technology
STOCKHOLM, Sweden, December 19, 2022 -- EnginZyme, a green tech company developing biomanufacturing processes for the sustainable manufacturing of everyday products, announced today that it had raised €21 million in a Series B financing round. New investors, including Almi Invest GreenTech, Navigare Ventures and Bunge Ventures, join existing investors Sofinnova Partners, Industrifonden and SEB GreenTech VC in the funding round.EnginZyme's goal is to put sustainable, biobased technology within reach of companies across various sectors. Its technology platform utilises nature’s catalysts,